Nephrogenic Systemic Fibrosis: Suspected Causative Role of Gadodiamide Used for Contrast-Enhanced Magnetic Resonance Imaging (Q22065113)
Jump to navigation
Jump to search
scientific article
- Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Nephrogenic Systemic Fibrosis: Suspected Causative Role of Gadodiamide Used for Contrast-Enhanced Magnetic Resonance Imaging |
scientific article |
|
Statements
Nephrogenic Systemic Fibrosis: Suspected Causative Role of Gadodiamide Used for Contrast-Enhanced Magnetic Resonance Imaging (English)
0 references
P. Marckmann
1 reference
Lone Skov
1 reference
Kristian Rossen
1 reference
Anders Dupont
1 reference
Mette Brimnes Damholt
1 reference
James Goya Heaf
1 reference
Henrik S Thomsen
1 reference
9 August 2006
0 references
17
0 references
9
0 references
2359-2362
0 references